SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea flag South Korea · Delayed Price · Currency is KRW
101,100
-400 (-0.39%)
At close: Sep 29, 2025

SK Biopharmaceuticals Market Cap

SK Biopharmaceuticals has a market cap or net worth of 7.95 trillion as of September 29, 2025. Its market cap has decreased by -11.74% in one year.

Market Cap
7.95T
Enterprise Value
7.82T
Revenue
620.28B
Ranking
n/a
PE Ratio
31.05
Stock Price
101,100.00

Market Cap Chart

Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 7.95T, a decrease of -20.08%. That is a compound annual growth rate of -4.18%.

History

DateMarket Cap% Change
Sep 29, 20257,917.47B-9.00%
Dec 30, 20248,700.60B10.66%
Dec 28, 20237,862.65B39.25%
Dec 29, 20225,646.39B-25.82%
Dec 30, 20217,612.05B-42.49%
Dec 30, 202013.23T33.07%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 71.17T
Celltrion 39.21T
ALTEOGEN 23.89T
Yuhan 8,582.33B
Peptron 6,470.56B
PharmaResearch 5,683.14B
LigaChem Biosciences 5,185.05B
ABL Bio 5,091.86B
Market Cap Rankings